Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
- PMID: 27799157
- PMCID: PMC5336409
- DOI: 10.1158/1055-9965.EPI-16-0693
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Abstract
Background: Although high-risk mutations in identified major susceptibility genes (DNA mismatch repair genes and MUTYH) account for some familial aggregation of colorectal cancer, their population prevalence and the causes of the remaining familial aggregation are not known.Methods: We studied the families of 5,744 colorectal cancer cases (probands) recruited from population cancer registries in the United States, Canada, and Australia and screened probands for mutations in mismatch repair genes and MUTYH We conducted modified segregation analyses using the cancer history of first-degree relatives, conditional on the proband's age at diagnosis. We estimated the prevalence of mutations in the identified genes, the prevalence of HR for unidentified major gene mutations, and the variance of the residual polygenic component.Results: We estimated that 1 in 279 of the population carry mutations in mismatch repair genes (MLH1 = 1 in 1,946, MSH2 = 1 in 2,841, MSH6 = 1 in 758, PMS2 = 1 in 714), 1 in 45 carry mutations in MUTYH, and 1 in 504 carry mutations associated with an average 31-fold increased risk of colorectal cancer in unidentified major genes. The estimated polygenic variance was reduced by 30% to 50% after allowing for unidentified major genes and decreased from 3.3 for age <40 years to 0.5 for age ≥70 years (equivalent to sibling relative risks of 5.1 to 1.3, respectively).Conclusions: Unidentified major genes might explain one third to one half of the missing heritability of colorectal cancer.Impact: Our findings could aid gene discovery and development of better colorectal cancer risk prediction models. Cancer Epidemiol Biomarkers Prev; 26(3); 404-12. ©2016 AACR.
©2016 American Association for Cancer Research.
Conflict of interest statement
The authors have no conflict of interest to declare with respect to this manuscript.
Figures
Similar articles
-
Colorectal cancer and advanced adenoma characteristics according to causative mismatch repair gene variant in Japanese colorectal surveillance for Lynch syndrome.J Gastroenterol. 2024 Aug;59(8):699-708. doi: 10.1007/s00535-024-02128-5. Epub 2024 Jun 21. J Gastroenterol. 2024. PMID: 38902413
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
-
The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.Campbell Syst Rev. 2024 Apr 21;20(2):e1396. doi: 10.1002/cl2.1396. eCollection 2024 Jun. Campbell Syst Rev. 2024. PMID: 38645303 Free PMC article. Review.
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article. Review.
Cited by
-
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7. Signal Transduct Target Ther. 2024. PMID: 39370455 Free PMC article. Review.
-
Clinicopathologic features of endometrial cancer with mismatch repair deficiency.Ecancermedicalscience. 2020 Jun 18;14:1061. doi: 10.3332/ecancer.2020.1061. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32582376 Free PMC article.
-
Modified capture-recapture estimates of the number of families with Lynch syndrome in Central Ohio.Fam Cancer. 2019 Jan;18(1):67-73. doi: 10.1007/s10689-018-0096-0. Fam Cancer. 2019. PMID: 30019097 Free PMC article.
-
MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome.Cancers (Basel). 2023 Jan 6;15(2):391. doi: 10.3390/cancers15020391. Cancers (Basel). 2023. PMID: 36672340 Free PMC article.
-
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.J Pathol. 2019 Apr;247(5):574-588. doi: 10.1002/path.5229. Epub 2019 Feb 20. J Pathol. 2019. PMID: 30584801 Free PMC article. Review.
References
-
- Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525–38. - PubMed
-
- Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895–2015. Nat Rev Cancer. 2015;15:181–94. - PubMed
-
- Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet. 2009;41:112–7. - PubMed
-
- Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat. 2009;30:197–203. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 CA074799/CA/NCI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- 20861/CRUK_/Cancer Research UK/United Kingdom
- 11174/CRUK_/Cancer Research UK/United Kingdom
- U01 CA167551/CA/NCI NIH HHS/United States
- HHSN261201300012I/CA/NCI NIH HHS/United States
- N01PC35142/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- N01 CN067009/CN/NCI NIH HHS/United States
- R01 CA170122/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- K05 CA152715/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous